Mi-Hyeong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mi-Hyeong Kim has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Jeong-Kye Hwang
Department of Surgery, Division of Vascular and Transplant Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
10 shared publications - Hyung-Jin Cho
Department of Surgery, Division of Vascular and Transplant Surgery, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
9 shared publications - Kang Woong Jun
Division of Vascular and Transplant Surgery, Department of Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 327 Sosa-ro, Bucheon-si 14647, Republic of Korea
8 shared publications - Juhwan Yoo
The Catholic University of Korea
4 shared publications - Kyung-Jai Ko
Department of Surgery, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea
4 shared publications - Kyungdo Han
Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
4 shared publications
Latest Publications
- 18 September 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58  (9) , 1733-1739
Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation
- 18 September 2026
- Published by Elsevier in Transplantation Proceedings
- Vol. 58  (9) , 1733-1739
Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation
- Open Access
- 19 May 2026
- Published by Elsevier in SSRN Electronic Journal
Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation
BackgroundEarly graft function is a critical predictor of long-term outcomes in kidney transplantation. This study evaluated 10-year outcomes in patients with suboptimal graft function (SGF) during the first month after deceased donor kidney transplantation (DDKT).MethodsIn this retrospective study of 294 adult DDKT recipients (February 2006 - January 2014), SGF was defined as the lowest serum creatinine >1.5 mg/dL during the first month. Cases with a creatinine ≤1.5 mg/dL were categorized as the standard outcome group. Primary outcomes were 10-year graft and patient survival.ResultsSuboptimal graft function was associated with significantly poorer long-term graft survival (5-year: 82.3% vs. 92.7%; 10-year: 63.2% vs. 89.1%). Overall mortality did not differ between groups. Delayed graft function alone showed no significant association with graft survival. Donor age ≥ 60 years was also associated with inferior graft survival.ConclusionSuboptimal early creatinine elevation is a significant predictor of long-term graft outcomes. Donor age is an important determinant of long-term graft outcomes.
- 19 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTen-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation
BackgroundEarly graft function is a critical predictor of long-term outcomes in kidney transplantation. This study evaluated 10-year outcomes in patients with suboptimal graft function (SGF) during the first month after deceased donor kidney transplantation (DDKT).MethodsIn this retrospective study of 294 adult DDKT recipients (February 2006 - January 2014), SGF was defined as the lowest serum creatinine >1.5 mg/dL during the first month. Cases with a creatinine ≤1.5 mg/dL were categorized as the standard outcome group. Primary outcomes were 10-year graft and patient survival.ResultsSuboptimal graft function was associated with significantly poorer long-term graft survival (5-year: 82.3% vs. 92.7%; 10-year: 63.2% vs. 89.1%). Overall mortality did not differ between groups. Delayed graft function alone showed no significant association with graft survival. Donor age ≥ 60 years was also associated with inferior graft survival.ConclusionSuboptimal early creatinine elevation is a significant predictor of long-term graft outcomes. Donor age is an important determinant of long-term graft outcomes.
- Open Access
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105  (17) , e48557
Perioperative outcomes and risk factors following common femoral endarterectomy: A multicenter retrospective study
Common femoral endarterectomy (CFE) remains essential in the endovascular era for treating common femoral artery disease and enabling hybrid revascularization. Despite its widespread use, contemporary data on outcomes and risk factors are limited. This retrospective multicenter study analyzed 150 consecutive CFE procedures performed at 2 Korean centers between January 2017 and February 2024. The primary endpoints were 6-month all-cause mortality and 3-month local complications. Univariate logistic regression was performed to identify potential risk factors. Although CFE is technically straightforward, it has meaningful perioperative risks, particularly in patients with chronic kidney disease, high American Society of Anesthesiologists scores, or chronic limb-threatening ischemia (CLTI). These findings underscore the importance of careful patient selection and perioperative optimization and highlight the need for vigilant postoperative monitoring even for this commonly performed procedure. The cohort included 150 limbs from 132 patients (mean age 72.2 ± 9.8 years; 72.7% male). Clinical presentations included claudication (45.3%), chronic limb-threatening ischemia (CLTI; 36.7%), acute limb ischemia (12.7%), and access-related indications (5.3%). Combined procedures were performed in 86.7% of the patients. The 6-month mortality rate was 6.7% (10/150), and 3-month local complications occurred in 7.3% of patients (11/150). The significant risk factors for mortality according to the univariate analysis included chronic kidney disease (odds ratio [OR] 4.19; 95% confidence interval [CI] 1.13–15.49; P = .037), an American Society of Anesthesiologists score ≥ 4 (OR 7.75; 95% CI 2.02–29.73; P = .005), and CLTI (OR 4.47; 95% CI 1.11–18.08; P = .038). A body mass index > 25 kg/m 2 was significantly associated with local complications (OR 4.01, 95% CI 1.15–14.02; P = .031). Subgroup analysis revealed no significant difference in outcomes between isolated CFE (n = 36) and combined CFE (n = 114).
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105  (17) , e48557
Open AccessPerioperative outcomes and risk factors following common femoral endarterectomy: A multicenter retrospective study
Common femoral endarterectomy (CFE) remains essential in the endovascular era for treating common femoral artery disease and enabling hybrid revascularization. Despite its widespread use, contemporary data on outcomes and risk factors are limited. This retrospective multicenter study analyzed 150 consecutive CFE procedures performed at 2 Korean centers between January 2017 and February 2024. The primary endpoints were 6-month all-cause mortality and 3-month local complications. Univariate logistic regression was performed to identify potential risk factors. Although CFE is technically straightforward, it has meaningful perioperative risks, particularly in patients with chronic kidney disease, high American Society of Anesthesiologists scores, or chronic limb-threatening ischemia (CLTI). These findings underscore the importance of careful patient selection and perioperative optimization and highlight the need for vigilant postoperative monitoring even for this commonly performed procedure. The cohort included 150 limbs from 132 patients (mean age 72.2 ± 9.8 years; 72.7% male). Clinical presentations included claudication (45.3%), chronic limb-threatening ischemia (CLTI; 36.7%), acute limb ischemia (12.7%), and access-related indications (5.3%). Combined procedures were performed in 86.7% of the patients. The 6-month mortality rate was 6.7% (10/150), and 3-month local complications occurred in 7.3% of patients (11/150). The significant risk factors for mortality according to the univariate analysis included chronic kidney disease (odds ratio [OR] 4.19; 95% confidence interval [CI] 1.13–15.49; P = .037), an American Society of Anesthesiologists score ≥ 4 (OR 7.75; 95% CI 2.02–29.73; P = .005), and CLTI (OR 4.47; 95% CI 1.11–18.08; P = .038). A body mass index > 25 kg/m 2 was significantly associated with local complications (OR 4.01, 95% CI 1.15–14.02; P = .031). Subgroup analysis revealed no significant difference in outcomes between isolated CFE (n = 36) and combined CFE (n = 114).
- Open Access
- 9 March 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
First deceased donor robotic kidney transplantation in Korea: a case report
Jisum Moon, Hyungjin Cho, Mihyeong Kim, Taehyun Ban, Bumsoon Choi, Sung Shin, Jeongkye Hwang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0092
- 9 March 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Open AccessFirst deceased donor robotic kidney transplantation in Korea: a case report
Jisum Moon, Hyungjin Cho, Mihyeong Kim, Taehyun Ban, Bumsoon Choi, Sung Shin, Jeongkye Hwang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0092
- Open Access
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105  (1) , e46169
Abdominal aortic aneurysm and gout risk: A nationwide population-based observational cohort study
Abdominal aortic aneurysm (AAA) is associated with systemic inflammatory processes that may influence metabolic disorders. This study investigated whether AAA is a risk factor for gout development and evaluated how different treatment approaches influence this risk. We conducted a nationwide retrospective cohort study using the Korean National Health Insurance Service database (2009–2015). We identified 14,256 newly diagnosed patients with AAA and matched them with 42,768 non-AAA controls at a 1:3 ratio based on age and sex. Participants were followed until December 31, 2019, with incident gout (International Classification of Diseases, 10th revision, M10) as the primary endpoint. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs). During the median follow-up of 6.3 years, the incidence of gout was significantly higher in AAA patients than in controls (21.75 vs 13.87 per 1000 person-years). After comprehensive adjustment for demographic, clinical, and lifestyle factors, AAA remained independently associated with increased gout risk (HR: 1.443, 95% CI: 1.325–1.573, P < .001). AAA patients who underwent surgical intervention had a significantly higher risk of developing gout (HR: 1.795, 95% CI: 1.583–2.035, P < .001) compared to non-AAA controls. Among surgical approaches, endovascular aneurysm repair (EVAR) was associated with a higher risk of gout (HR: 1.862, 95% CI: 1.616–2.146, P < .001) than open surgical aneurysm repair (OSAR) (HR: 1.658, 95% CI: 1.363–2.018, P < .001). AAA is an independent risk factor for gout development, with surgical intervention further increasing this risk, particularly following EVAR procedures. These findings have important implications for metabolic monitoring in AAA patients, especially those undergoing endovascular interventions.
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105  (1) , e46169
Open AccessAbdominal aortic aneurysm and gout risk: A nationwide population-based observational cohort study
Abdominal aortic aneurysm (AAA) is associated with systemic inflammatory processes that may influence metabolic disorders. This study investigated whether AAA is a risk factor for gout development and evaluated how different treatment approaches influence this risk. We conducted a nationwide retrospective cohort study using the Korean National Health Insurance Service database (2009–2015). We identified 14,256 newly diagnosed patients with AAA and matched them with 42,768 non-AAA controls at a 1:3 ratio based on age and sex. Participants were followed until December 31, 2019, with incident gout (International Classification of Diseases, 10th revision, M10) as the primary endpoint. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs). During the median follow-up of 6.3 years, the incidence of gout was significantly higher in AAA patients than in controls (21.75 vs 13.87 per 1000 person-years). After comprehensive adjustment for demographic, clinical, and lifestyle factors, AAA remained independently associated with increased gout risk (HR: 1.443, 95% CI: 1.325–1.573, P < .001). AAA patients who underwent surgical intervention had a significantly higher risk of developing gout (HR: 1.795, 95% CI: 1.583–2.035, P < .001) compared to non-AAA controls. Among surgical approaches, endovascular aneurysm repair (EVAR) was associated with a higher risk of gout (HR: 1.862, 95% CI: 1.616–2.146, P < .001) than open surgical aneurysm repair (OSAR) (HR: 1.658, 95% CI: 1.363–2.018, P < .001). AAA is an independent risk factor for gout development, with surgical intervention further increasing this risk, particularly following EVAR procedures. These findings have important implications for metabolic monitoring in AAA patients, especially those undergoing endovascular interventions.
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111  (3) , 170-176
Pattern and prognosis of perioperative deep vein thrombosis after hip fracture: a single-center retrospective cohort study
Shin J, et al. Ann Surg Treat Res. 2026 Sep;111(3):170-176. https://doi.org/10.4174/astr.2026.111.3.170
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111  (3) , 170-176
Open AccessPattern and prognosis of perioperative deep vein thrombosis after hip fracture: a single-center retrospective cohort study
Shin J, et al. Ann Surg Treat Res. 2026 Sep;111(3):170-176. https://doi.org/10.4174/astr.2026.111.3.170
- Open Access
- 21 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15  (23) , 2948
Machine Learning-Based Algorithm for Tacrolimus Dose Optimization in Hospitalized Kidney Transplant Patients
Background: Tacrolimus is a cornerstone immunosuppressant in kidney transplantation, but its narrow therapeutic index and marked inter-patient variability complicate dose optimization. Conventional therapeutic drug monitoring (TDM) relies on empirical adjustments that often overlook individual pharmacokinetics. Machine learning (ML) offers a precision dosing alternative by integrating diverse clinical and biochemical variables into predictive models. Methods: We retrospectively analyzed 1351 data points from 87 kidney transplant patients at Eunpyeong St. Mary’s Hospital (April 2019–November 2023). Clinical, demographic, and laboratory information, including tacrolimus trough levels and dosing history, were extracted from electronic medical records. Four predictive models—XGBoost, CatBoost, LightGBM, and a multilayer perceptron (MLP)—were trained to forecast next-day tacrolimus concentrations, and model serum creatinine level performance was evaluated using R-squared (R2), mean absolute error (MAE), and root-mean-squared error (RMSE). An ensemble model with weighted soft voting was applied to enhance predictive accuracy, and model interpretability was assessed using SHapley Additive exPlanations (SHAP). Results: The ensemble model achieved the best overall performance (R2 = 0.6297, MAE = 1.0181, RMSE = 1.2999), outperforming all individual models, whereas the MLP model showed superior predictive power among single models, reflecting the significance of nonlinear interactions in tacrolimus pharmacokinetics. SHAP analysis highlighted prior tacrolimus levels, cumulative dose, renal function markers (eGFR level, serum creatinine level), and albumin concentration as the most influential predictors. Conclusions: We present a robust ML-based algorithm for tacrolimus dose optimization in hospitalized kidney transplant recipients. By improving predictions of tacrolimus concentrations, the model may help reduce inter-patient dose variability and lower the risk of nephrotoxicity, supporting safer and more individualized immunosuppressive management. This approach advances AI-driven precision medicine in transplant care, offering a pathway to safer and more effective immunosuppression.
- 21 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15  (23) , 2948
Open AccessMachine Learning-Based Algorithm for Tacrolimus Dose Optimization in Hospitalized Kidney Transplant Patients
Background: Tacrolimus is a cornerstone immunosuppressant in kidney transplantation, but its narrow therapeutic index and marked inter-patient variability complicate dose optimization. Conventional therapeutic drug monitoring (TDM) relies on empirical adjustments that often overlook individual pharmacokinetics. Machine learning (ML) offers a precision dosing alternative by integrating diverse clinical and biochemical variables into predictive models. Methods: We retrospectively analyzed 1351 data points from 87 kidney transplant patients at Eunpyeong St. Mary’s Hospital (April 2019–November 2023). Clinical, demographic, and laboratory information, including tacrolimus trough levels and dosing history, were extracted from electronic medical records. Four predictive models—XGBoost, CatBoost, LightGBM, and a multilayer perceptron (MLP)—were trained to forecast next-day tacrolimus concentrations, and model serum creatinine level performance was evaluated using R-squared (R2), mean absolute error (MAE), and root-mean-squared error (RMSE). An ensemble model with weighted soft voting was applied to enhance predictive accuracy, and model interpretability was assessed using SHapley Additive exPlanations (SHAP). Results: The ensemble model achieved the best overall performance (R2 = 0.6297, MAE = 1.0181, RMSE = 1.2999), outperforming all individual models, whereas the MLP model showed superior predictive power among single models, reflecting the significance of nonlinear interactions in tacrolimus pharmacokinetics. SHAP analysis highlighted prior tacrolimus levels, cumulative dose, renal function markers (eGFR level, serum creatinine level), and albumin concentration as the most influential predictors. Conclusions: We present a robust ML-based algorithm for tacrolimus dose optimization in hospitalized kidney transplant recipients. By improving predictions of tacrolimus concentrations, the model may help reduce inter-patient dose variability and lower the risk of nephrotoxicity, supporting safer and more individualized immunosuppressive management. This approach advances AI-driven precision medicine in transplant care, offering a pathway to safer and more effective immunosuppression.
- Open Access
- 23 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25  (1) , 1-11
Proteinuria is risk factor for abdominal aortic aneurysm: a nationwide population-based study
Background: Proteinuria is a well-known risk factor for cardiovascular disease. However, the impact of proteinuria on abdominal aortic aneurysm (AAA) remains unclear. In this study, we aimed to investigate the association between proteinuria and AAA. To assess the correlation between proteinuria measured by the urine dipstick test (UDT) and the risk of AAA by using nationwide population cohort data. Methods: This retrospective cohort study used data from the Korean National Health Insurance database for individuals who had health check-ups in 2009. Incident AAA was ascertained through the end of 2019. The study population was classified into the following five groups based on the UDT result: negative; trace; 1+; 2+; and ≥ 3+. The primary endpoint was newly developed AAA during the study period. Results: A total of 9,938,329 patients were enrolled. During a median follow-up of 9.3 years (interquartile range 9.1–9.6), 20,760 (0.2%) AAA events were identified, and the incidence rates of AAA were 2.21, 2.55, 4.20, 5.77 and 7.49 per 10,000 per year in the negative, trace, 1+, 2 + and 3 + ≤ proteinuria groups, respectively, compared with those without proteinuria (P <.001). There was a positive correlation between the degree of proteinuria and the risk of AAA, which was consistent regardless of all estimated glomerular filtration rate categories. Conclusion: Proteinuria as measured by the UDT was strongly associated with AAA and acted as an independent risk factor. These findings suggest that proteinuria may serve as a potential marker for identifying individuals at higher risk of AAA.
- 23 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25  (1) , 1-11
Open AccessProteinuria is risk factor for abdominal aortic aneurysm: a nationwide population-based study
Background: Proteinuria is a well-known risk factor for cardiovascular disease. However, the impact of proteinuria on abdominal aortic aneurysm (AAA) remains unclear. In this study, we aimed to investigate the association between proteinuria and AAA. To assess the correlation between proteinuria measured by the urine dipstick test (UDT) and the risk of AAA by using nationwide population cohort data. Methods: This retrospective cohort study used data from the Korean National Health Insurance database for individuals who had health check-ups in 2009. Incident AAA was ascertained through the end of 2019. The study population was classified into the following five groups based on the UDT result: negative; trace; 1+; 2+; and ≥ 3+. The primary endpoint was newly developed AAA during the study period. Results: A total of 9,938,329 patients were enrolled. During a median follow-up of 9.3 years (interquartile range 9.1–9.6), 20,760 (0.2%) AAA events were identified, and the incidence rates of AAA were 2.21, 2.55, 4.20, 5.77 and 7.49 per 10,000 per year in the negative, trace, 1+, 2 + and 3 + ≤ proteinuria groups, respectively, compared with those without proteinuria (P <.001). There was a positive correlation between the degree of proteinuria and the risk of AAA, which was consistent regardless of all estimated glomerular filtration rate categories. Conclusion: Proteinuria as measured by the UDT was strongly associated with AAA and acted as an independent risk factor. These findings suggest that proteinuria may serve as a potential marker for identifying individuals at higher risk of AAA.
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108  (1) , 31-38
Evaluation of health-related quality of life and performance in intestinal transplant and rehabilitation patients: a cross-sectional study
Jang E, et al. Ann Surg Treat Res. 2025 Jan;108(1):31-38. https://doi.org/10.4174/astr.2025.108.1.31
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108  (1) , 31-38
Open AccessEvaluation of health-related quality of life and performance in intestinal transplant and rehabilitation patients: a cross-sectional study
Jang E, et al. Ann Surg Treat Res. 2025 Jan;108(1):31-38. https://doi.org/10.4174/astr.2025.108.1.31
- Open Access
- 23 October 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57  (3) , 715-722
Increased risk of genitourinary cancer in kidney transplant recipients: a large-scale national cohort study and its clinical implications
Purpose To investigate the risk of genitourinary (GU) cancer in kidney transplant recipients (KTRs) compared to that in the general population, focusing on potential risk factors and clinical implications. Methods Using a national cohort of approximately 360,000 individuals, including 31,542 KTRs, we conducted a retrospective analysis of the data from 2007 to 2018. Propensity score matching was used to compare KTRs with a healthy population, adjusting for age, sex, diabetes, hypertension, and hypercholesterolemia. Results We identified a significantly increased risk of GU cancers, particularly bladder and kidney cancers, in KTRs. Multivariate analysis revealed a higher risk of GU cancer associated with kidney transplantation [hazard ratio (HR) 2.133, 95% confidence interval (CI) 1.641–2.772] and hypercholesterolemia (HR 1.725, 95% CI 1.227–2.425), with older age and male sex also being significant risk factors. Conversely, no significant increase in prostate cancer risk was observed in KTRs compared to the general population. Conclusion This national cohort-based study indicated an increased risk of GU cancer in KTRs, underscoring the need for targeted cancer surveillance and pre- and post-transplant counseling. These findings provide valuable insights for the development of cancer surveillance programs for KTRs and highlight the necessity for further research in this field.
- 23 October 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57  (3) , 715-722
Open AccessIncreased risk of genitourinary cancer in kidney transplant recipients: a large-scale national cohort study and its clinical implications
Purpose To investigate the risk of genitourinary (GU) cancer in kidney transplant recipients (KTRs) compared to that in the general population, focusing on potential risk factors and clinical implications. Methods Using a national cohort of approximately 360,000 individuals, including 31,542 KTRs, we conducted a retrospective analysis of the data from 2007 to 2018. Propensity score matching was used to compare KTRs with a healthy population, adjusting for age, sex, diabetes, hypertension, and hypercholesterolemia. Results We identified a significantly increased risk of GU cancers, particularly bladder and kidney cancers, in KTRs. Multivariate analysis revealed a higher risk of GU cancer associated with kidney transplantation [hazard ratio (HR) 2.133, 95% confidence interval (CI) 1.641–2.772] and hypercholesterolemia (HR 1.725, 95% CI 1.227–2.425), with older age and male sex also being significant risk factors. Conversely, no significant increase in prostate cancer risk was observed in KTRs compared to the general population. Conclusion This national cohort-based study indicated an increased risk of GU cancer in KTRs, underscoring the need for targeted cancer surveillance and pre- and post-transplant counseling. These findings provide valuable insights for the development of cancer surveillance programs for KTRs and highlight the necessity for further research in this field.